The MT-2 peptide market in 2006 represents a pivotal point in the evolution of synthetic melanocortin analogues. This report analyzes the product composition, research trends, and industry growth surrounding MT-2, a synthetic analogue of α-MSH. Evaluated for its melanogenic and metabolic applications, the peptide has garnered significant attention from cosmetic formulators, research laboratories, and bulk raw material distributors. Comparative data from that period highlight variations in purity, formulation, and bioactivity across suppliers, while research trends indicate rising interest in dermatological and metabolic studies. This analysis provides a selection guide based on regulatory status, stability, and cost-effectiveness, supporting informed procurement and application decisions for B2B buyers.
Core Molecular Specs & Technical Index
Understanding the technical specifications of MT-2 is critical for procurement professionals. The peptide is a linear, synthetic tridecapeptide amide with a molecular formula of C50H68N14O10S and a molecular weight of approximately 1024.2 g/mol. Its sequence is Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which provides enhanced stability and receptor affinity compared to native α-MSH.
- Purity Standard: Industry-grade MT-2 typically requires ≥98% purity by HPLC for research and cosmetic applications, with premium grades reaching ≥99% for advanced metabolic studies.
- Solubility Profile: The peptide is freely soluble in water and saline solutions at concentrations up to 10 mg/mL, with optimal solubility achieved at pH 5-6 using sterile water for injection.
- Storage Conditions: Lyophilized powder must be stored at -20°C or below, protected from light and moisture, to maintain stability for up to 24 months. Reconstituted solutions should be used within 7 days when refrigerated.
- Bioactivity Assay: Standard activity is measured via cAMP accumulation in B16-F10 melanoma cells, with typical EC50 values ranging from 0.1-1.0 nM, confirming potent melanocortin-1 receptor (MC1R) activation.
- Endotoxin Levels: For injectable-grade material, endotoxin levels must be <1.0 EU/mg, ensuring suitability for in vivo research protocols without pyrogenic reactions.
Industry data from 2006 indicates that the global MT-2 peptide market was valued at approximately $4.2 million, with a compound annual growth rate (CAGR) of 12.5% projected through 2010. The dermatological research segment accounted for 58% of demand, driven by studies on melanogenesis and photoprotection.
Manufacturing & Quality Control
The production of MT-2 peptide follows solid-phase peptide synthesis (SPPS) using Fmoc chemistry, a method that ensures high yield and reproducibility. The process begins with resin loading, followed by sequential amino acid coupling, deprotection, and cleavage. Post-synthesis, the crude peptide undergoes purification via preparative reverse-phase high-performance liquid chromatography (RP-HPLC) to achieve the desired purity threshold.
Quality control protocols are rigorous and multi-layered. Each batch is subjected to analytical HPLC for purity assessment, mass spectrometry (MS) for molecular weight confirmation, and amino acid analysis (AAA) for sequence verification. Third-party testing by independent laboratories is standard practice for B2B transactions, providing certificates of analysis (CoA) that document all critical parameters.
- Certificate of Analysis (CoA): Includes HPLC chromatogram, MS spectrum, and purity percentage for each batch.
- Stability Studies: Accelerated stability testing at 40°C/75% RH for 4 weeks confirms shelf-life projections.
- Heavy Metal Testing: ICP-MS analysis ensures levels of lead, arsenic, cadmium, and mercury are below ICH Q3D limits.
- Residual Solvent Analysis: GC-MS verification that acetonitrile and TFA levels are within pharmacopoeial limits.
- Bioactivity Verification: Cell-based assay confirms functional activity against MC1R receptors.
Commercial Application Scenarios
MT-2 peptide finds diverse applications across cosmetic formulation, laboratory research, and bulk wholesale distribution. In cosmetic formulation, it is incorporated into topical creams and serums at concentrations of 0.01-0.05% for skin brightening and photoprotection studies. The peptide's ability to stimulate melanogenesis without UV exposure makes it a valuable tool for developing self-tanning products and pigmentary disorder treatments.
In laboratory research, MT-2 is used extensively for metabolic studies investigating energy homeostasis and appetite regulation. Researchers administer the peptide via subcutaneous injection at doses of 0.5-1.0 mg/kg in rodent models to evaluate effects on food intake, body weight, and insulin sensitivity. The peptide's long half-life (approximately 2-3 hours in vivo) allows for sustained pharmacological effects.
Bulk wholesale usage cases include supply to contract research organizations (CROs) conducting preclinical trials, as well as to cosmetic ingredient distributors serving the nutricosmetics market. Typical bulk orders range from 1 gram to 100 grams, with custom packaging options available for GMP-compliant facilities. The peptide is often supplied as a lyophilized powder in sterile vials, with desiccants and moisture barrier bags to ensure stability during transit.
MT-2 Peptide VS Ordinary Low-Grade Peptides
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥99% by HPLC | 90-95% by HPLC | Higher purity reduces side reactions and improves reproducibility |
| Stability | 24 months at -20°C | 6-12 months at -20°C | Extended shelf life reduces waste and inventory costs |
| Bioactivity | EC50 <0.5 nM | EC50 1-5 nM | Potent activity allows lower dosing in research protocols |
| Cost-Effectiveness | $120/gram (bulk) | $80-150/gram | Competitive pricing with superior quality metrics |
Bulk Purchase Selection Guide
When procuring MT-2 peptide in bulk, buyers must navigate common pitfalls to ensure product quality and regulatory compliance. One frequent issue is misrepresentation of purity, where suppliers claim ≥98% but deliver material with significant impurities that affect bioactivity. Another pitfall is inadequate documentation, particularly missing certificates of analysis or stability data, which can lead to batch failures in downstream applications.
Selection standards should prioritize suppliers with transparent manufacturing processes, including GMP certification and third-party testing. Buyers should request samples for in-house validation before committing to large orders. Key criteria include HPLC purity ≥98%, endotoxin levels <1.0 EU/mg, and confirmed bioactivity via cell-based assays. Additionally, suppliers should provide detailed stability data under recommended storage conditions.
- Verify Supplier Credentials: Check for ISO 9001 or GMP certification and request references from existing B2B clients.
- Request Batch Documentation: Obtain CoA, MSDS, and stability reports for each batch before purchase.
- Evaluate Packaging: Ensure lyophilized powder is sealed in vacuum-tight vials with desiccants to prevent moisture absorption.
- Assess Shipping Conditions: Confirm that shipments use temperature-controlled packaging with dry ice for international orders.
- Negotiate Quality Agreements: Establish clear specifications for purity, bioactivity, and endotoxin levels in purchase contracts.
Core Product Advantages
The MT-2 peptide offered by our company delivers distinct advantages in purity, stability, cost performance, and technical support. Our product achieves ≥99% purity by HPLC, verified by independent third-party laboratories, ensuring consistent results in research and formulation applications. The peptide exhibits exceptional stability, maintaining full bioactivity for 24 months when stored at -20°C, which reduces inventory turnover and minimizes waste.
Cost performance is optimized through efficient manufacturing processes that achieve high yields without compromising quality. Our bulk pricing at $120 per gram for orders over 10 grams provides significant savings compared to competitors offering similar purity levels. Technical support includes access to application scientists who can assist with reconstitution protocols, stability testing, and formulation guidance, ensuring seamless integration into your workflows.
Additional advantages include customizable packaging options, from 1-gram vials to 100-gram bulk containers, with GMP-compliant labeling and documentation. We offer expedited shipping for urgent orders and maintain a dedicated customer service team for B2B clients, providing rapid response times and personalized support. Our commitment to quality is reflected in our rigorous quality control protocols, which include batch-to-batch consistency testing and comprehensive stability studies.
Frequently Asked Questions
Q1: What is the recommended storage condition for MT-2 peptide to maintain long-term stability?
A1: Lyophilized MT-2 peptide should be stored at -20°C or below, protected from light and moisture. Under these conditions, the peptide remains stable for up to 24 months. Reconstituted solutions should be used within 7 days when refrigerated at 2-8°C, or aliquoted and frozen at -20°C for extended use.
Q2: How is the purity of MT-2 peptide verified, and what is the acceptable threshold for research applications?
A2: Purity is verified by analytical HPLC with UV detection at 214 nm and 280 nm. For research applications, a purity of ≥98% is standard, while premium grades for metabolic studies require ≥99%. Mass spectrometry is used to confirm molecular weight, and amino acid analysis validates sequence integrity.
Q3: What are the key differences between MT-2 and other melanocortin analogues for cosmetic formulation?
A3: MT-2 has a longer half-life and higher receptor affinity compared to native α-MSH, making it more effective at lower concentrations. Unlike some analogues, MT-2 does not require UV activation for melanogenesis, offering greater formulation flexibility. However, it may cause transient side effects such as nausea or flushing at higher doses, which must be considered in product development.